A sulfate polysaccharide/TNF-related apoptosis-inducing ligand (TRAIL) complex for the long-term delivery of TRAIL in poly(lactic-co-glycolic acid) (PLGA) microspheres

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 1, 2013, Pages 11-21

  Kim, Hyemin ^a   Jeong, Dooyong ^a   Kang, Hee Eun ^a   Lee, Kang Choon ^b   Na, Kun ^a  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

chondroitin sulfate; long term delivery; PLGA microspheres; sustained release; TRAIL

Indexed keywords

CHONDROITIN SULFATE; MICROSPHERE; POLYGLACTIN; POLYSACCHARIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOLECULAR WEIGHT; MOUSE; NANOPHARMACEUTICS; NEOPLASM; NONHUMAN; PH; TUMOR XENOGRAFT; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CHONDROITIN SULFATES; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEMALE; HELA CELLS; HUMANS; LACTIC ACID; MALE; MICE; MICE, INBRED ICR; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; RECOMBINANT FUSION PROTEINS; SOLUBILITY; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84870948815     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01564.x     Document Type: Article

References (24)

1. Van Der Sloot AM, et al,. Stabilization of TRAIL, an all-β-sheet multimeric protein, using computational redesign. Protein Eng Des Sel 2004; 9: 673-680.
2. Griffith TS, et al,. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 1998; 6: 2833-2840.
3. Kelley SK, Ashkenazi A,. Targeting death receptors in cancer with Apo2L/TRAIL. Curr Opin Pharmacol 2004; 4: 333-339.
4. Ashkenazi A, Dixit VM,. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 2: 255-260.
5. Wiley SR, et al,. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 6: 673-682.
6. Na SJ, et al,. Stability and bioactivity of nanocomplex of TNF-related apoptosis-inducing ligand. Int J Pharm 2008; 1-2: 149-154.
7. Athanasiou KA, et al,. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996; 2: 93-102.
8. Meurette O, et al,. TRAIL (TNF-related apoptosis-inducing ligand) induces necrosis-like cell death in tumor cells at acidic extracellular pH. Ann N Y Acad Sci 2005; 1: 379-387.
9. Kim TH, et al,. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained-release PLGA microspheres for enhanced stability and antitumor activity. J Control Release 2010; 1: 63-69.
10. Kim TH, et al,. PEGylated TNF-Related Apoptosis-Inducing Ligand (TRAIL) Analogs: Pharmacokinetics and Anti-tumor Effects. Bioconjug Chem 2011; 8: 1631-1637.
11. Cohen S, et al,. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharm Res 1991; 6: 713-720.
12. Menei P, et al,. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma. Cancer 1999; 2: 325-330.
13. Blanco D, Alonso MJ,. Protein encapsulation and release from poly (lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur J Pharm Biopharm 1998; 3: 285-294.
14. Crotts G, Park TG,. Protein delivery from poly (lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J Microencapsul 1998; 6: 699-713.
15. Lu W, Park TG,. Protein release from poly (lactic-co-glycolic acid) microspheres: protein stability problems. PDA J Pharm Sci Technol 1995; 1: 13-19.
16. Lee ES, et al,. Protein complexed with chondroitin sulfate in poly (lactide-co-glycolide) microspheres. Biomaterials 2007; 17: 2754-2762.
17. Trowbridge JM, Gallo RL,. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 2002; 9: 117-125.
18. Lee ES, et al,. In vitro study of lysozyme in poly (lactide-co-glycolide) microspheres with sucrose acetate isobutyrate. Eur J Pharm Sci 2006; 5: 435-441.
19. Ashkenazi A, et al,. Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J Clin Oncol 2008; 21: 3621-3630.
20. Oldham J, et al,. Biological activity of rhBMP-2 released from PLGA microspheres. J Biomech Eng 2000; 3: 289-292.
21. Costantino HR, et al,. Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. J Pharm Sci 2002; 2: 388-395.
22. Zolnik BS, et al,. Elevated temperature accelerated release testing of PLGA microspheres. J Control Release 2006; 3: 293-300.
23. Giteau A, et al,. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm 2007; 1-2: 14-26.
24. Bhandari N, Raghubir P,. Modulation of selected cell signaling genes in mouse liver by fumonisin B1. Chem Biol Interact 2002; 3: 317-331.